OXYGENTA PHARMACEUTICAL
Back to All Ratios
|
OXYGENTA PHARMACEUTICAL Last 5 Year Cash Earnings per Share (CEPS) History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| CEPS(Rs) | -4.12 | -1.81 | -0.24 | -6.70 | 0.69 |
What is the latest Cash Earnings per Share (CEPS) ratio of OXYGENTA PHARMACEUTICAL ?
| Year | Cash Earnings per Share (CEPS) |
|---|---|
| Mar2026 | -4.12 |
| Mar2025 | -1.81 |
| Mar2024 | -0.24 |
| Mar2023 | -6.70 |
| Mar2022 | 0.69 |
How is Cash Earnings per Share (CEPS) of OXYGENTA PHARMACEUTICAL Trending?
| Years | Cash Earnings per Share (CEPS) | % Change | |
|---|---|---|---|
| Mar2026 | -4.12 | Negative | |
| Mar2025 | -1.81 | Negative | |
| Mar2024 | -0.24 | Negative | |
| Mar2023 | -6.7 | Negative | |
| Mar2022 | 0.69 | - | |
Other Financial Ratios of OXYGENTA PHARMACEUTICAL
| Operational & Financial Ratios Earnings Per Share DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Cash Earnings per Share (CEPS) ratio of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹181.4 Cr | -1.2% | 5% | -52.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,270.0 Cr | -1.4% | 2.4% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹222,224.0 Cr | 12.2% | 23.1% | 21.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,325.0 Cr | 2.4% | 5.3% | 41.7% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | 1.7% | 0.7% | -3.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,876.6 Cr | 3% | -14.9% | -10.2% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | -1.2% |
5% |
-52.3% |
| SENSEX | 2.2% |
0.9% |
-3.7% |
You may also like the below Video Courses